HCI Group Announces Proposed $115 Million Offering of Convertible Senior Notes Due 2037
Feb 28, 2017 11:00 am UTC| Business
TAMPA, Fla., Feb. 28, 2017 -- HCI Group, Inc. (NYSE:HCI), today announced its intention to offer, subject to market and other conditions, $115 million aggregate principal amount of convertible senior notes due 2037 (the...
EXL Announces $100 Million Share Repurchase Program
Feb 28, 2017 11:00 am UTC| Business
NEW YORK, Feb. 28, 2017 -- ExlService Holdings, Inc. (NASDAQ:EXLS) today announced that its Board of Directors has authorized an additional $100 million common stock repurchase program, effective immediately. The...
Cesca Therapeutics Strengthens Leadership Team and Board of Directors
Feb 28, 2017 11:00 am UTC| Business
Appoints Ms. Vivian Liu as Chief Operating Officer Elects Dr. Russell Medford to its board of directors RANCHO CORDOVA, Calif., Feb. 28, 2017 -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated...
Sprague Resources LP Announces Conversion of Subordinated Units to Common Units
Feb 28, 2017 11:00 am UTC| Business
PORTSMOUTH, N.H., Feb. 28, 2017 -- Sprague Resources LP (“Sprague”) (NYSE:SRLP) announced today that on February 27, 2017, the board of directors of the Partnership’s general partner confirmed and approved that, with...
Cabot Microelectronics to Hold Annual Meeting of Stockholders on March 7
Feb 28, 2017 11:00 am UTC| Business
Aurora, IL, Feb. 28, 2017 -- Cabot Microelectronics Corporation (Nasdaq: CCMP), the world’s leading supplier of chemical mechanical planarization (CMP) polishing slurries and a growing CMP pad supplier to the...
Feb 28, 2017 10:39 am UTC| Business
Hamilton, Bermuda, February 28, 2017 Nordic American Tankers Limited announced that it yesterday took delivery of Nordic Space, its second Suezmax newbuilding tanker of 158,000 deadweight tons, built at Sungdong...
Affimed to Present at the Cowen and Company 37th Annual Health Care Conference
Feb 28, 2017 10:01 am UTC| Business
Heidelberg, Germany, February 28, 2017 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today that Dr....